Statistics for Development of recombinant vaccines to prevent the disease caused by the respiratory viruses SARS-CoV-2, hMPV, and hRSV
Total visits
| views | |
|---|---|
| Development of recombinant vaccines to prevent the disease caused by the respiratory viruses SARS-CoV-2, hMPV, and hRSV | 162 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 1 |
| August 2025 | 3 |
| September 2025 | 0 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| Consolidated_Thesis_manuscript_vAug_25_22.pdf | 123 |
Top country views
| views | |
|---|---|
| United States | 52 |
| Chile | 13 |
| China | 8 |
| India | 6 |
| Argentina | 3 |
| Indonesia | 2 |
| Japan | 2 |
| Germany | 1 |
| United Kingdom | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| South Korea | 1 |
| Mexico | 1 |
| Netherlands | 1 |
| Romania | 1 |
Top city views
| views | |
|---|---|
| Miami | 35 |
| Santiago | 11 |
| Louisville | 7 |
| Alameda | 4 |
| Beijing | 4 |
| Buenos Aires | 3 |
| New Delhi | 3 |
| Bandung | 2 |
| Noida | 2 |
| Andover | 1 |
| Athens | 1 |
| Central District | 1 |
| Chengdu | 1 |
| Cluj-napoca | 1 |
| Costa Mesa | 1 |
| Dublin | 1 |
| Edinburgh | 1 |
| Fukuoka | 1 |
| Gyeongsan | 1 |
| Köln | 1 |
| Sacramento | 1 |
| Yonezawa | 1 |
| Zapopan | 1 |